Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 5 (2008), Issue 7 (July)

1. Schwannoma of the intermediate nerve.
   J Neurosurg, 109(1): 144-8. [Abstract] [Full-text]
2. Metachronous mature teratoma in the corpus callosum occurring 12 years after a pineal germinoma.
   J Neurosurg, 109(1): 126-9. [Abstract] [Full-text]
3. Identification of a human leukocyte antigen-A24-restricted T-cell epitope derived from interleukin-13 receptor alpha2 chain, a glioma-associated antigen.
   J Neurosurg, 109(1): 117-22. [Abstract] [Full-text]
4. Effect of ropivacaine skull block on perioperative outcomes in patients with supratentorial brain tumors and comparison with remifentanil: a pilot study.
   J Neurosurg, 109(1): 44-9. [Abstract] [Full-text]
5. Thyroid-stimulating hormone pituitary adenomas.
   J Neurosurg, 109(1): 17-22. [Abstract] [Full-text]
6. Outcomes following endoscopic, expanded endonasal resection of suprasellar craniopharyngiomas: a case series.
   J Neurosurg, 109(1): 6-16. [Abstract] [Full-text]
7. Extraventricular neurocytoma in neurofibromatosis Type 1: case report.
   J Neurosurg Pediatrics, 2(1): 63-7. [Abstract] [Full-text]
8. The asleep-awake technique using propofol-remifentanil anaesthesia for awake craniotomy for cerebral tumours.
   Eur J Anaesthesiol, 25(8): 662-9. [Abstract] [Full-text]
9. Endoscopic transnasal craniotomy and the resection of craniopharyngioma.
   Laryngoscope, 118(7): 1142-8. [Abstract] [Full-text]
10. Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression.
    Clin Cancer Res, 14(13): 4154-60. [Abstract] [Full-text]
11. Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis.
    Br J Cancer, 99(1): 160-6. [Abstract] [Full-text]
12. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.
    Am J Surg Pathol, 32(7): 1051-9. [Abstract] [Full-text]
13. Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.
    J Clin Oncol, 26(20): 3387-94. [Abstract] [Full-text]
14. FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities.
    Oncogene, 27(30): 4180-90. [Abstract] [Full-text]
15. Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas.
    Cancer Genet Cytogenet, 184(2): 77-86. [Abstract] [Full-text]
16. Phosphatase and tensin homologue and pituitary tumor-transforming gene in pituitary adenomas. Clinical-pathologic and immunohistochemical analysis.
    Ann Diagn Pathol, 12(4): 275-82. [Abstract] [Full-text]
17. Modulation of CD59 expression by restrictive silencer factor-derived peptides in cancer immunotherapy for neuroblastoma.
    Cancer Res, 68(14): 5979-87. [Abstract] [Full-text]
18. Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients.
    Cancer Res, 68(14): 5955-64. [Abstract] [Full-text]
19. New insights into tumor microstructure using temporal diffusion spectroscopy.
    Cancer Res, 68(14): 5941-7. [Abstract] [Full-text]
20. Noninvasive assessment of E2F-1-mediated transcriptional regulation in vivo.
    Cancer Res, 68(14): 5932-40. [Abstract] [Full-text]
21. Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells.
    Cancer Res, 68(14): 5778-84. [Abstract] [Full-text]
22. Merlin is a potent inhibitor of glioma growth.
    Cancer Res, 68(14): 5733-42. [Abstract] [Full-text]
23. PAX8 regulates telomerase reverse transcriptase and telomerase RNA component in glioma.
    Cancer Res, 68(14): 5724-32. [Abstract] [Full-text]
24. Temozolomide preferentially depletes cancer stem cells in glioblastoma.
    Cancer Res, 68(14): 5706-15. [Abstract] [Full-text]
25. Primary angiosarcoma of the brain in a child.
    Fetal Pediatr Pathol, 27(3): 175-83. [Abstract] [Full-text]
26. Presurgical functional MR imaging of language and motor functions: validation with intraoperative electrocortical mapping.
    Radiology, 248(2): 579-89. [Abstract] [Full-text]
27. Resveratrol and X rays affect gap junction intercellular communications in human glioblastoma cells.
    Mol Carcinog, 47(8): 587-98. [Abstract] [Full-text]
28. Initial testing of VNP40101M (Cloretazine) by the pediatric preclinical testing program.
    Pediatr Blood Cancer, 51(3): 439-41. [Abstract] [Full-text]
29. Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.
    Endocrinology, 149(8): 4158-67. [Abstract] [Full-text]
30. Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme.
    Int J Cancer, 123(6): 1364-75. [Abstract] [Full-text]
31. c-Myc and beta-catenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in mice.
    Oncogene, 27(32): 4392-401. [Abstract] [Full-text]
32. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.
    Lab Invest, 88(8): 808-15. [Abstract] [Full-text]
33. Treatment-related changes in functional connectivity in brain tumor patients: a magnetoencephalography study.
    Exp Neurol, 212(2): 285-90. [Abstract] [Full-text]
34. Vision-related quality of life in patients with pituitary adenoma.
    Am J Ophthalmol, 146(2): 318-322. [Abstract] [Full-text]
35. Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival.
    Hum Pathol, 39(8): 1143-52. [Abstract] [Full-text]
36. Pharmacologic blockade of chloride channel synergistically enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells.
    Biochem Biophys Res Commun, 373(4): 539-44. [Abstract] [Full-text]
37. Invited article: the expanding impact of molecular biology on the diagnosis and treatment of gliomas.
    Neurology, 71(5): 365-73. [Abstract] [Full-text]
38. Biomolecular characterization of human glioblastoma cells in primary cultures: differentiating and antiangiogenic effects of natural and synthetic PPARgamma agonists.
    J Cell Physiol, 217(1): 93-102. [Abstract] [Full-text]
39. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
    Am J Surg Pathol, 32(8): 1220-7. [Abstract] [Full-text]
40. Lysophosphatidylserine stimulates chemotactic migration in U87 human glioma cells.
    Biochem Biophys Res Commun, 374(1): 147-51. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.